Lunit invites you to their event

Implementing AI in the symptomatic breast clinic and outline of the prospective trial at Leeds Teaching Hospital NHS Trust

About this event


🗒️About this presentation

During Eusobi 2023, Dr. Nisha Sharma from the Leeds Teaching Hospital NHS Trust presented her upcoming research aiming to assess the performance of AI in the symptomatic breast clinic, utilizing Lunit INSIGHT MMG. This is the world's first prospective AI study in a symptomatic breast clinic setting.

👉 Read more: Click here


📌Highlights

  • Evaluation to establish Lunit INSIGHT MMG's non-inferiority when used with a human reader, compared to the current double human reading approach.
  • Evaluation aims to improve breast cancer screening efficiency and address the challenges posed by workforce shortages and increasing retirements among breast radiologists


📢 About the Speaker: Dr. Nisha Sharma

  • Consultant Breast Radiologist
  • Director of Breast Screening Leeds/Wakefield
  • Lead Clinician for Breast and Quality & Plain films - Leeds Teaching Hospital NHS Trust
  • MBChB, BSC(hons), MRCP, FRCR, MSC


🛑 Lunit INSIGHT MMG

Lunit INSIGHT MMG is an AI solution that detects breast cancer on mammograms with 96% accuracy.

Validated by studies published in the Lancet Digital Health, JAMA Oncology, and many more, Lunit INSIGHT MMG can improve your diagnostic performance, especially for dense breasts as well as detect breast cancers earlier.

Based on its proven accuracy, you can reduce false-negative cases and recall rates, which ultimately can address the shortage of breast specialists in a single and double-reading environment.

Hosted by

  • Team member
    T
    Team Lunit Lunit

Lunit

Conquer Cancer through AI

With an accuracy rate of 96-99%, our AI can empower you to achieve the highest level of accuracy in finding cancer and critical findings.

Lunit AI for chest x-ray and 2D & 3D mammography has been validated through 160+ studies and is now in use in over 2,300 sites globally.